白雲山(600332.SH):Alliance BMP向公司提出延長售股權行權期
格隆匯5月31日丨白雲山(600332.SH)公佈,2021年5月31日,公司(“買方”)與Alliance BMP Limited(“賣方”)、廣州醫藥股份有限公司(原廣州醫藥有限公司,“廣州醫藥”)簽署《Alliance BMP Limited與廣州白雲山醫藥集團股份有限公司與廣州醫藥股份有限公司關於廣州醫藥有限公司30%股權的轉讓合同之補充合同》,約定將《Alliance BMP Limited與廣州白雲山醫藥集團股份有限公司與廣州醫藥有限公司關於廣州醫藥有限公司30%股權的轉讓合同》項下約定的售股權的行權期由交割日後滿六(6)個月之日起至交割日後滿三十六(36)個月之日止內的任何時間修改為在交割日後滿六(6)個月之日起至交割日後滿四十二(42)個月之日和廣州醫藥的H股於聯交所主板公開上市及買賣之第一日兩者的孰早時間止內的任何時間。
廣州醫藥已向聯交所遞交了上市申請表格(A1表格),申請其H股在聯交所主板上市及買賣,鑑於廣州醫藥的上市仍處於申請階段,賣方向公司提出延長售股權行權期。
本次延長售股權行權期是為穩步推進廣州醫藥上市進程,經雙方協商後做出的決定,預計不會對公司、廣州醫藥的分拆上市產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.